Updated July 2026 The Ozempic and GLP-1 gastroparesis lawsuits involve claims that manufacturers of GLP-1 medications such as Ozempic, Wegovy, Mounjaro, Rybelsus, Trulicity, Zepbound, and Saxenda failed to adequately warn patients and doctors about the potential risk of developing gastroparesis (i.e., stomach paralysis or delayed gastric emptying), a serious gastrointestinal injury that can cause persistent nausea, vomiting, abdominal pain, bloating, dehydration, malnutrition, hospitalization, or the need for feeding tubes or other invasive treatment
In addition, the weight loss stimulated by liraglutide may help to improve blood sugar control and outcomes from diabetes
Using lipo B and lipo C together means you're targeting both sides of the fat metabolism equation
Professional Distribution Only
These microorganisms play a key role in preserving the integrity of the intestinal mucosa, maintaining immune homeostasis, and mitigating the risk of metabolic, inflammatory, and chronic diseases
The two pathways are complementary, not redundant
